Analyzing Calmare Therapeutics (OTCMKTS:CTTC) & Restoration Robotics (OTCMKTS:HAIR)

Share on StockTwits

Calmare Therapeutics (OTCMKTS:CTTC) and Restoration Robotics (NASDAQ:HAIR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, earnings, analyst recommendations and profitability.

Analyst Ratings

This is a summary of recent recommendations for Calmare Therapeutics and Restoration Robotics, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Calmare Therapeutics 0 0 0 0 N/A
Restoration Robotics 0 3 0 0 2.00

Restoration Robotics has a consensus target price of $2.62, suggesting a potential upside of 429.29%. Given Restoration Robotics’ higher probable upside, analysts clearly believe Restoration Robotics is more favorable than Calmare Therapeutics.

Insider and Institutional Ownership

0.5% of Calmare Therapeutics shares are owned by institutional investors. Comparatively, 20.0% of Restoration Robotics shares are owned by institutional investors. 17.5% of Calmare Therapeutics shares are owned by company insiders. Comparatively, 37.8% of Restoration Robotics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Valuation and Earnings

This table compares Calmare Therapeutics and Restoration Robotics’ revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Calmare Therapeutics $1.11 million 4.01 -$3.82 million N/A N/A
Restoration Robotics $21.96 million 0.92 -$28.73 million ($0.86) -0.58

Calmare Therapeutics has higher earnings, but lower revenue than Restoration Robotics.

Risk & Volatility

Calmare Therapeutics has a beta of 0.74, suggesting that its stock price is 26% less volatile than the S&P 500. Comparatively, Restoration Robotics has a beta of 4.16, suggesting that its stock price is 316% more volatile than the S&P 500.

Profitability

This table compares Calmare Therapeutics and Restoration Robotics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Calmare Therapeutics N/A N/A N/A
Restoration Robotics -128.59% -1,909.87% -90.10%

Calmare Therapeutics Company Profile

Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pain. The company was formerly known as Competitive Technologies, Inc. and changed its name to Calmare Therapeutics Incorporated in August 2014. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut.

Restoration Robotics Company Profile

Restoration Robotics, Inc., a medical device company, develops and commercializes image-guided robotic systems in the United States and internationally. The company offers ARTAS System, a physician-assisted robotic system that identifies and dissects hair follicular units directly from the scalp and creates recipient implant sites. Its system includes the ARTAS Hair Studio application, an interactive three-dimensional patient consultation tool that enables a physician to create a simulated hair transplant model for use in patient consultations. The company was founded in 2002 and is headquartered in San Jose, California.

Receive News & Ratings for Calmare Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calmare Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.